New pill aims to ease chemo nerve damage in early trial
NCT ID NCT07601386
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase study tests a new tablet, JMKX000189, in 18 adults with cancer who have nerve pain or numbness from chemotherapy. The main goal is to check safety and side effects, while also seeing if the drug can reduce pain and numbness. Participants must have solid tumors and no other cause of nerve problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Huashan Hospital Fudan University
Shanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug shield nerves from Chemotherapy's side effects?
- Smartwatch could spot nerve damage before it starts
- Could simple leg exercises restore balance and blood flow after chemotherapy?
- Could a simple vibrating pad ease chemo nerve damage?
- Zapping the brain to ease chemo nerve pain: a new hope for breast cancer survivors
- Blood test may predict nerve damage from common chemo drug